Key Facts
Analyses regularly the health records of 56 million individuals; Business Intelligence partners of Arden & GEM CSU in support of over 60 CCGs; Free global web service for Coronavirus risk assessment launched
Successes in UK/NHS
Using its AI methodology - i5’s study on Non-Medical Prescribing increased NHS investment into nurse education nationally; i5 analysis presented the NHS in London with £3 billion, in the seventh year, of potential returns on digital investments; i5 Targeted Social Prescribing (i5 TSP) on-line tool provided to all CCGs in London; i5 Diagnosis Stratification (i5 DST) is identifying as yet undiagnosed sufferers from LTCs; i5 analysis is centring the national programme on Evidence Based Interventions (EBI).Company details
Solutions
Driving insights and analysis
Specialism
Healthcare Data insights
Company details
Want to connect with this innovator?
Make an enquiryWebsite
www.i5health.comDetails
View on Companies HouseMarkets already exporting to
UK, France, Germany, Kingdom of Saudi Arabia, United Arab Emirates, Chile, Colombia, Mexico. The on-line i5 Coronavirus Health Risk Calculator is global. Kingdom of Saudi Arabia – where i5 is appreciated for its AI tools and is engaging personally with HE the Minister and HE the Vice Minister. Trials of i5 DST are commencing in Chile, Colombia and Mexico.
Desired Markets
The rest of the GCC, North and South America, India, Indonesia, Australia
Desired customer types
PHM Authorities, Hospital Management, Clinicians and Insurers